Deficiency in the enzyme adenosine deaminase (ADA) in humans manifests prim
arily as severe lymphopenia and immunodeficiency, resulting in death by 6 m
onths of age, if untreated. In this review, we discuss phenotypical, bioche
mical, and metabolic hallmarks of the disease, and describe a mouse model i
n which levels of ADA can be biochemically and genetically manipulated. Thi
s model provides exciting possibilities for uncovering the mechanisms by wh
ich this purine catabolic enzyme affects lymphopoiesis. (C) 2000 Academic P
ress.